drugset / Trial / NCT01454778
Effects of Paclitaxel on Intimal Hyperplasia
NaSingle-groupOpen-labelPrevention
Summary
This is a single, one time, limited dose infusion of Paclitaxel, that will potentially prevent recurrent stenosis secondary to intimal hyperplasia when compared to the control group at 10 months.
Timeline
- Start
- 2011-04
- Primary completion
- 2014-10
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 1.4 mg | — |
| Subject | Paclitaxel | Small molecule | 1.8 mg | — |
| Subject | Paclitaxel | Small molecule | 2.4 mg | — |